All In Biotech

Free tool

FAERS Monitor: Phenylephrine Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207926 or its brand name (Phenylephrine Hydrochloride, Phenylephrine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

3,598

Serious

3,445

96% of reports

Hospitalization

2,148

Death reported

1,812

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,363
  • pemphigus1,074
  • joint swelling1,038
  • pain1,004
  • maternal exposure during pregnancy1,003
  • infusion related reaction996
  • glossodynia995
  • rheumatoid arthritis993
  • drug ineffective984
  • pericarditis983
  • systemic lupus erythematosus981
  • wound966
  • synovitis963
  • hepatic enzyme increased945
  • folliculitis922

Reports by year received

View as table
YearReports
20042
200514
20066
200715
200815
20098
201043
201118
201252
201329
201416
201527
201628
201746
201846
201961
2020109
2021123
2022267
2023318
2024976
2025995
2026384

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,561 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
folliculitisSignal922563.4531.1471,891
pemphigusSignal1,074549.3520.7537,137
pericarditisSignal983363.2343.6334,269
synovitisSignal963329.7311.7298,717
glossodyniaSignal995271.9257.4256,607
woundSignal966209.2198.0193,325
systemic lupus erythematosusSignal981166.1157.3156,676
infusion related reactionSignal99689.284.585,702
hepatic enzyme increasedSignal94582.277.774,870
maternal exposure during pregnancySignal1,00366.563.164,212
rheumatoid arthritisSignal99351.648.949,028
joint swellingSignal1,03850.748.150,371
painSignal1,0049.69.17,914
off label useSignal1,3639.18.710,246
drug ineffectiveSignal9844.44.12,720

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.